Commercialization: Page 33
-
PharmaVoice Team/PharmaVoice
Pharma Trax
High-value Specialty Medicines are Driving Growth in the Generics Market Trending now: Emerging markets are the next big opportunity after the United States. Increased life expectancy, a growing older-population cohort, and the higher incidence of chronic lifestyle-related diseases are encouragi...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Medidata Introduces Payment Technology for Clinical Trial Sites Trending Now: The market’s first end-to-end cloud-based reimbursement tool uses clinical trial data to calculate costs and disburse payment to investigative sites in real time. Medidata has launched Medidata Payments. A new compone...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
Biomedical Literature Product Released Trending now: AI Platform Forms Basis for Discovery Tool Quertle LLC, a developer of the first artificial intelligence (AI) biomedical big data platform (BioAI), has released Qinsight. The product uses BioAI’s neural networks and other AI methods, along with...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Global Site Solutions Summit, produced by the Society for Clinical Research Sites (SCRS), is committed to being “the site’s meeting." The conference provides a unique hub where sites, sponsors, CRO executives, and regulators come together and share best practices; build the...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Providing Global Access Isabel Torres, Global Head, Access to Medicines Initiative, Takeda, talks about the company’s strategy for providing access to its medicines in less developed healthcare systems. PV: What is your vision for the Access to Medicines Initiative? Torres: We wanted to expand ou...
By Isabel Torres • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth in Clinical Research
Mobile technology could revolutionize clinical research. Sensors, wearable devices, and mobile apps have the potential to offer pharmaceutical sponsors access to patient data that complement existing data and provide a more complete view of safety and efficacy. The number of U.S. consumers who us...
By Denise Myshko • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Specialty Drug Market
As specialty drugs continue to earn a greater share of the pharmaceutical market, marketing, sales, and key opinion leader (KOL) professionals are faced with addressing market access issues, while needing to create an attractive value proposition for physicians. Going forward, these roles will e...
By Robin Robinson • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Advertising to the Masses
Earlier this year, eMarketer predicted that digital ad spending across all industries would surpass TV for the first time in 2017. Overall, TV ad spending will total $72.01 billion, or 35.8% of total media ad spending; digital ad spending in 2017 will equal $77.37 billion, or 38.4% of total ad sp...
By Robin Robinson • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Evolution of Patient Communities
Patient and community outreach have changed over the last decade. Patient organizations and pharmaceutical companies have been building communities, especially online communities of patients, because they recognize the opportunity to provide support and information exchange. Social media has had ...
By Denise Myshko • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
French Connection: Picture of an Evolving Market
France is the second-largest European market and one of the world’s largest consumers of pharmaceutical products. The French pharmaceutical industry grew by 17.9% between 2000 and 2010, compared with growth of 6.1% in the manufacturing sector. This performance can be explained by solid scientific...
By Kim Ribbink • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions: Patients Are No Longer Patient for Solutions
Over the past few years, the term patient-centric has been used so frequently that it almost has no meaning. But despite the centricity over the concept, the strategy of putting patients squarely in the middle of what the industry is doing and where it needs to go is sound. In parallel, the conce...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Helping Patients Help Themselves
One of the biggest challenges in healthcare begins the moment a patient steps out of the doctor’s office or clinic. Suddenly, that individual assumes the bulk of responsibility for managing his or her condition on a daily basis — day after day, good mood or bad, on vacations, at work and at home....
By Jennifer Sigaud • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Creating a More Efficient, Effective, and Easier Model for Patient Care
It’s a challenge that continues to keep many pharmaceutical leaders up at night: how to advance patient-oriented programs in an industry addicted to the use of middlemen. A myriad of players, including PBMs (pharmacy benefit managers), wholesalers, specialty pharmacies, and other “hub" service co...
By Marie Lamont • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Addressing Whole Patient Needs: A New Model for Pharma
In today’s healthcare environment, there is more pressure to deliver optimal patient outcomes with greater efficiency. Traditional marketing approaches that rely on messaging to promote patient acceptance of therapy and adherence are not enough to drive real-world impact. To stay relevant, the ph...
By Jessica Brueggeman • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Not "Patients," But People
Finding Inspiration on Customer-Centric Marketing From Other Walks of Life Let’s not be healthcare marketers for a moment. Let’s be us: men, women, parents, grandparents, grandchildren, children, aunts, uncles, even pet parents. Sometimes we get sick. Our loved ones may suffer a heart attack. Alz...
By Johanna Skilling • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Personal Patient Connections Generate Real-world Results
In today’s plugged in, non-stop digital world, pharma brands are finding that helping patients create a personal, ongoing connection with a healthcare professional is a core catalyst for adherence to therapy, a more satisfying patient journey, brand loyalty, and — ultimately — improved patient ou...
By Abigail Mallon • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Supply Chain: The Pharma Supply Chain
The pharmaceutical supply chain is a complex system through which prescription medicines, biologics, and devices are delivered to patients. The Kaiser Family Foundation lays out the distribution channel as such: products originate in manufacturing sites, they are then transferred to wholesale dis...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Key Questions to Ask When making Critical Channel Decisions
As the process of bringing new products to market has become increasingly complex, so too have decisions around distribution and channel strategy. When thinking about how to get products into the hands of providers and patients in the right place and at the right time, pharmaceutical companies ha...
By Jennifer Fillman • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Speak Out
Including the Elderly in Clinical Trials: A Challenge for the Ages, Solutions for Today Provided by: Artcraft Health Written by: Allison Musante, ELS Allison Musante is a copywriter and editor at Artcraft Health, a full-service health education and marketing communications agency. She has served ...
By Allison Musante • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Battery-less, Stretchable Patch Provides More Options for Health Monitoring Trending now: Innovative solutions lead to next generation mHealth tools. John Rogers, Ph.D., founder of MC10 and a materials scientist at the University of Illinois at Urbana-Champaign, has introduced a wearable electro...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
Digitas Health LifeBrands Announces Partnership with Dreamit Trending now: Agency connects with global accelerator to drive business velocity. Digitas Health LifeBrands, a leading digital agency, has formed a strategic partnership with Dreamit, a top 10 global accelerator, aimed at driving busine...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Study Reveals High Confidence in Digital Transformation Success Despite Major Challenges Trending now: Almost 70% of executives still predict digital transformation success in the face of major corporate roadblocks. While a majority of companies expect to meet digital transformation objectives i...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Quintiles Unveils Solution Design Studio Trending now: New healthcare technology and apps accelerator combines expert teams and agile processes in a highly collaborative, digitally enabled environment. Quintiles, a provider of product development and integrated healthcare services, has opened it...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
A Call for Commercial Transformation
The implementation of digital technologies will have a great impact on the way pharma marketers engage with both patients and healthcare professionals. The impact will be in terms of amplified time and efficiency, much better sales and marketing alignment, the ability to customize by audience, an...
By Robin Robinson • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Digital Advertising: Investment Slowly Climbs
Think back over the past 24 hours of your life; how many hours — or even minutes — of that time were you engaged with a mobile device? If you said none, you are in the minority. Statistics from several mobile industry reports say 64% of U.S. adults own a smartphone (Pew), 54% use mobile over comp...
By Robin Robinson • Sept. 1, 2016
Previous
